Summary of Significant Accounting Policies (Details) (USD $)	2 Months Ended	3 Months Ended		6 Months Ended	12 Months Ended		0 Months Ended	1 Months Ended
	Mar. 07, 2013	Dec. 31, 2014	Sep. 30, 2014	Dec. 31, 2014	Dec. 31, 2014	Dec. 31, 2013	Sep. 09, 2014	Sep. 30, 2014	Jul. 30, 2014	Jul. 31, 2014	Aug. 31, 2013	Feb. 03, 2015	Jan. 30, 2015
Significant Accounting Policies [Line Items]
Receivable Balance,net allowances for doubtful debts		$ 7,810,417		$ 7,810,417	$ 7,810,417	$ 6,225,923
Allowance for doubtful accounts		2,071,706		2,071,706	2,071,706	2,404,659					257,000
Revenue from pharmaceutical clients					2,124,130	7,789,985
Line of credit, expiration date	Mar. 07, 2015
Line of credit, borrowing base percentage of pharmaceutical accounts receivable		80.00%		80.00%	80.00%
Line of credit, interest above prime rate						1.00%
Line of credit, interest charged				5.50%	5.00%
Line of credit, amount drawn		1,500,000		1,500,000	1,500,000	1,000,000
Advertising costs					62,793	16,677
Payment period from the date of invoice	45 days
Cash and cash equivalents that exceeded federally insured limits		1,960,623		1,960,623	1,960,623	7,726,681
Payments for Fees					40,000
Loans Receivable, Description of Variable Rate Basis					2.25%
Bad debt expense					5,842,212	3,165,918
Line of Credit Facility, Initiation Date					Jul. 14, 2011
Cash, Uninsured Amount		6,571		6,571	6,571	6,969
Line of Credit Facility, Maximum Borrowing Capacity							8,500,000		2,000,000
Adjustments to Additional Paid in Capital, Warrant Issued					377,140
Additional allowance for accounts receivable						690,000
Allowance For Doubtful Accounts Percentage Of Accounts Receivable		100.00%		100.00%	100.00%
Compensating Balance, Amount		4,000,000		4,000,000	4,000,000
Royalty Expense		240,077	240,077		480,154
Cost of Revenue					437,865
Licensing Agreements [Member]
Significant Accounting Policies [Line Items]
License Costs					42,289	305,616
Initial Warrant [Member]
Significant Accounting Policies [Line Items]
Class of Warrant or Right, Number of Securities Called by Warrants or Rights							681,090		681,090
Fair value Of Warrants Issued							377,140		377,140
Conversion of Stock Conversion Price Per Share								$ 0.55	$ 0.55
Fair Value Assumptions, Risk Free Interest Rate								2.01%	2.01%
Fair Value Assumptions, Expected Dividend Rate								0.00%	0.00%
Fair Value Assumptions, Expected Volatility Rate								101.50%	101.50%
Fair Value Assumptions, Expected Term							6 years			6 years
Class of Warrant or Right, Exercise Price of Warrants or Rights			$ 0.936					$ 0.936	$ 0.936
First Amendment Warrant [Member]
Significant Accounting Policies [Line Items]
Class of Warrant or Right, Number of Securities Called by Warrants or Rights							576,923
Class of Warrant or Right, Exercise Price of Warrants or Rights							$ 0.39
SG Financial LLC [Member] | Initial Warrant [Member]
Significant Accounting Policies [Line Items]
Class of Warrant or Right, Number of Securities Called by Warrants or Rights							200,321
Subsequent Event [Member]
Significant Accounting Policies [Line Items]
Line of Credit Facility, Commitment Fee Amount					750,000
Line of Credit Facility, Remaining Borrowing Capacity		2,000,000		2,000,000	2,000,000
Line of Credit Facility, Commitment Fee Percentage					15.00%
Subsequent Event [Member] | Initial Warrant [Member]
Significant Accounting Policies [Line Items]
Class of Warrant or Right, Number of Securities Called by Warrants or Rights												681,090
Class of Warrant or Right, Exercise Price of Warrants or Rights												$ 0.936
Subsequent Event [Member] | First Amendment Warrant [Member]
Significant Accounting Policies [Line Items]
Class of Warrant or Right, Number of Securities Called by Warrants or Rights												576,923	576,923
Class of Warrant or Right, Exercise Price of Warrants or Rights												$ 0.39	$ 0.39
Subsequent Event [Member] | SG Financial LLC [Member] | Initial Warrant [Member]
Significant Accounting Policies [Line Items]
Class of Warrant or Right, Number of Securities Called by Warrants or Rights													200,321
Maximum [Member]
Significant Accounting Policies [Line Items]
Line of credit, fee for unused portion					0.375%
Minimum [Member]
Significant Accounting Policies [Line Items]
Line of credit, fee for unused portion					0.25%
SWK Credit Agreement [Member]
Significant Accounting Policies [Line Items]
Long-term Debt, Gross									12,000,000
Line of Credit Facility, Interest Rate Description					The Loan bears interest at a rate equal to the LIBOR Rate (as defined in the SWK Credit Agreement) plus an applicable margin of 12.5% per annum, subject to a one percent (1.0%) LIBOR floor. Interest on the Loan is due and payable in arrears (i) on the forty-fifth
Line of Credit Facility, Current Borrowing Capacity							2,500,000
Line of Credit Facility, Commitment Fee Amount							1,029,412
Loans Payable		8,500,000		8,500,000	8,500,000
Debt Issuance Cost					576,161
Adjustments to Additional Paid in Capital, Warrant Issued					377,140
Deferred Finance Costs, Net		187,092		187,092	187,092
SWK Credit Agreement [Member] | Subsequent Event [Member]
Significant Accounting Policies [Line Items]
Line of Credit Facility, Current Borrowing Capacity		10,000,000		10,000,000	10,000,000
Line of Credit Facility, Increase (Decrease), Net					1,500,000
Medicare Program [Member]
Significant Accounting Policies [Line Items]
Percentage Of Revenue					38.00%	33.50%
Cost of Goods, Total [Member] | Supplier Concentration Risk [Member]
Significant Accounting Policies [Line Items]
Concentration risk percentage					73.00%	87.00%
Roche Molecular Systems [Member]
Significant Accounting Policies [Line Items]
Royalty Expense					211,932	280,325
Clinical [Member]
Significant Accounting Policies [Line Items]
Receivable Balance,net allowances for doubtful debts		1,037,834		1,037,834	1,037,834	1,892,384
Payment period from the date of invoice					45 days
ResponseDX [Member]
Significant Accounting Policies [Line Items]
Allowance for doubtful accounts		2,071,706		2,071,706	2,071,706	2,404,659
Bad debt expense					5,842,212	3,165,918
Silicon Valley Bank [Member]
Significant Accounting Policies [Line Items]
Line of Credit Facility, Maximum Borrowing Capacity		500,000		500,000	500,000	1,000,000
Line of Credit Facility, Capacity Available for Trade Purchases		12,000,000		12,000,000	12,000,000
Line Of Credit Facility Covenant Compliance Liquidity Amount		1,000,000
Silicon Valley Bank [Member] | Maximum [Member]
Significant Accounting Policies [Line Items]
Adjusted Quick Ratio					1.25
Silicon Valley Bank [Member] | Minimum [Member]
Significant Accounting Policies [Line Items]
Adjusted Quick Ratio					$ 1.00